A peer-reviewed review of mesenchymal stromal cell signaling, remyelination research in multiple sclerosis, and neural protection studies in Parkinson’s disease.
Recently, researchers transplanted stem cells into patients suffering from Parkinson’s Disease and observed promising results, particularly with respect to the safety of using stem cells in this group of patients. The specific type of stem cells used are called autologous bone-marrow-derived mesenchymal stem cells. These cells have been deemed promising candidates for treating Parkinson’s patients…
Parkinson’s disease is a progressive neurodegenerative disorder that causes tremor,rigidity, changes in facial expression, and several other symptoms. Whilesufferers usually retain their full cognitive abilities and memory, they tendto be impacted in mood and some mental health conditions that emerge as part ofthe condition process. Parkinson’s disease is caused by loss of brain cells in…
Parkinson’s disease affects movement by changing how brain cells communicate, especially those responsible for dopamine production. At Stemedix, we work with individuals and families to help them understand these changes through structured clinical review and education. These cellular changes often lead to symptoms such as tremors, stiffness, and slowed movement. Regenerative therapy for Parkinson’s disease…
Parkinson’s disease affects movement, coordination, and daily function over time, which is why long-term care planning matters. At Stemedix, we work with patients who already have a confirmed diagnosis and are exploring structured regenerative therapy options. You share your medical records with us, and we review them to understand your condition history before any care…
Understanding Parkinson’s Disease Parkinson’s disease is a progressive neurological condition that affects movement, coordination, and quality of life. It’s closely linked to the gradual loss of dopamine-producing neurons, which are important for smooth and controlled movement. Common symptoms may include tremors, stiffness, slowed movement, balance changes, and difficulty with coordination. While current treatments can help…
stem cell therapy for Parkinson disease’s disease (PD) is one of the most common neurodegenerative conditions, second only to Alzheimer’s. It primarily affects the basal nuclei of the brain, leading to the gradual loss of dopamine-producing neurons and the buildup of abnormal protein clusters called Lewy bodies. Together, these changes cause the classic motor and…
Parkinson’s disease (PD) is a common, progressive neurological disorder that primarily affects movement. It occurs when brain cells that produce a chemical called dopamine begin to die, particularly in a part of the brain called the substantia nigra. Dopamine plays a crucial role in controlling movement, so when these cells are lost, people experience symptoms…
Neurodegenerative diseases like Parkinson’s disease (PD), Alzheimer’s disease (AD), and amyotrophic lateral sclerosis (ALS) are among the most challenging medical conditions to treat. These disorders involve the gradual breakdown and loss of neurons in specific areas of the nervous system, leading to symptoms such as memory loss, paralysis, and impaired movement or cognition. Despite decades…
stem cell therapy for Parkinson disease's disease (PD) is a neurodegenerative disorder affecting millions worldwide, causing debilitating symptoms such as tremors, rigidity, and difficulty walking. Existing treatments primarily manage symptoms without addressing the underlying causes, highlighting the need for more effective therapeutic approaches. Mesenchymal stem cell (MSC) therapy has emerged as a promising option, demonstrating…
We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!